Latest On China SXT Pharmaceuticals, Inc (SXTC):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-10 20:55 EST | News | China SXT Pharmaceuticals receives 180-day extension to regain Nasdaq minimum bid price compliance | N/A |  |
| 2022-05-18 14:05 EST | News | China SXT Pharmaceuticals announces 1-for-20 reverse stock split | N/A | |
| 2022-03-29 12:04 EST | News | China SXT Pharmaceuticals climbs on heavy volume | N/A | |
| 2022-03-15 09:55 EST | News | China SXT Pharmaceuticals to raise $2.8M in convertible promissory note offering | N/A | |
| 2022-01-18 11:17 EST | News | China SXT Pharmaceuticals slumps on pricing $3.5M stock, pre-funded warrants offering | N/A | |
| 2021-12-16 14:24 EST | News | China SXT Pharmaceuticals receives Nasdaq notification for minimum bid price requirement | N/A | |
| 2021-02-23 00:49 EST | Stock Split | A stock split has occured on Feb 22, 2021 with a split factor of 1:4. | Neutral | |
| 2021-02-19 16:46 EST | News | China SXT Pharmaceuticals announces 1:4 reverse share split | N/A | |
| 2021-01-31 18:10 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-26 21:42 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-08 01:01 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 17:15 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 14:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 06:22 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-10 06:18 EST | News | China SXT Pharmaceuticals granted 180-day extension to regain compliance with Nasdaq | N/A | |
| 2020-08-14 10:15 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 09:38 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-02 13:39 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 17:59 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 05:57 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-29 22:04 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 13:53 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 18:35 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 10:06 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 17:53 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-19 13:46 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-14 05:49 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 06:16 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-27 06:23 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-21 01:57 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-06 06:31 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-01 05:54 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-26 05:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-03 21:57 EST | Financials | Company financials have been released. | Neutral | |
| 2020-03-25 21:34 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-28 05:07 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-27 22:52 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-22 00:49 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-18 00:34 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-13 00:49 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-07 00:55 EST | Financials | Company financials have been released. | Neutral | |
| 2020-02-01 00:51 EST | Financials | Company financials have been released. | Neutral | |
| 2020-01-29 00:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-01-28 00:53 EST | Financials | Company financials have been released. | Neutral | |
| 2020-01-25 00:39 EST | Financials | Company financials have been released. | Neutral | |
| 2020-01-16 00:54 EST | Financials | Company financials have been released. | Neutral | |
| 2019-12-22 00:23 EST | Financials | Company financials have been released. | Neutral | |
| 2019-12-17 00:40 EST | Financials | Company financials have been released. | Neutral | |
| 2019-11-29 00:26 EST | Financials | Company financials have been released. | Neutral | |
| 2019-11-28 00:37 EST | Financials | Company financials have been released. | Neutral | |
About China SXT Pharmaceuticals, Inc (SXTC):
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine piece tablets (TCMP) in China. It offers advanced, fine, and regular TCMP products, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. The company provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. As of May 2, 2020, it served 116 pharmaceutical companies, 56 pharmacies, and 76 hospitals. The company was founded in 2005 and is based in Taizhou, China.
General
- Name China SXT Pharmaceuticals, Inc
- Symbol SXTC
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- Full Time Employees 97
- Last Split Factor1:4
- Last Split Date2021-02-22
- Fiscal Year EndMarch
- IPO Date2019-01-04
- Gic SectorConsumer Staples
- Gic GroupHousehold & Personal Products
- Gic IndustryPersonal Products
- Gic SubIndustryPersonal Products
- Web URLhttp://www.sxtchina.com
View More
Valuation
- Trailing PE 12.51
- Price/Sales (Trailing 12 Mt.) 3.06
- Price/Book (Most Recent Quarter) 1.49
- Enterprise Value Revenue 2.98
- Enterprise Value EBITDA 40.79
View More
Financials
- Most Recent Quarter 2020-09-30
- Profit Margin -113%
- Operating Margin 1%
- Return on Equity -44%
- Revenue 5.81 million
- Earnings Per Share $0.08
- Revenue Per Share $0.58
- Gross Profit 2.7 million
- Quarterly Earnings Growth 20.1%
View More
Highlights
- Market Capitalization 35.22 million
- EBITDA 424668
- Book Value Per Share $1.19
View More
Share Statistics
- Shares Outstanding 15.51 million
- Shares Float 11.96 million
- % Held by Insiders 1370%
- % Held by Institutions 8.29%
- Shares Short 327342
- Shares Short Prior Month 360558
- Short Ratio 0.12
- Short % of Float 2%
- Short % of Shares Outstanding 2%
View More
Technicals
- Beta -0.23
- 52 Week High $5.12
- 52 Week Low $0.89
- 50 Day Moving Average 2.75
- 200 Day Moving Average 1.69
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
China SXT Pharmaceuticals, Inc (SXTC) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
China SXT Pharmaceuticals, Inc (SXTC) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-06-30 | 2020-09-30 | $N/A | $0.05 | $0.00 | |
| 2020-03-31 | 2020-06-30 | $N/A | $0.05 | $0.00 | |
| 2019-12-31 | 2020-03-31 | $N/A | -$0.60 | $0.00 | |
| 2019-09-30 | 2019-12-31 | $N/A | -$0.60 | $0.00 | |
| 2019-06-30 | 2019-09-30 | $N/A | -$0.21 | $0.00 | |
| 2019-03-31 | 2019-06-30 | $1.55 million | -$0.21 | $0.00 | |
| 2018-12-31 | 2019-03-31 | $1.55 million | $0.05 | $0.00 | |
| 2018-09-30 | 2018-12-31 | $1.96 million | $0.05 | $0.00 | |
| 2018-06-30 | 2018-09-30 | $1.96 million | $0.10 | $0.00 | |
| 2018-03-31 | 2018-06-30 | $1.43 million | $0.10 | $0.00 | |
| 2017-12-31 | 2018-03-31 | $N/A | $0.04 | $0.00 | |
| 2017-06-30 | 2017-09-30 | $N/A | $0.08 | $0.00 | |
| 2017-03-31 | 2017-06-30 | $4.88 million | $0.08 | $0.00 | |
| 2016-12-31 | 2017-03-31 | $N/A | $0.08 | $0.00 |
China SXT Pharmaceuticals, Inc (SXTC) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | N/A | N/A | N/A | N/A |
| Income Before Tax | N/A | N/A | N/A | N/A | N/A |
| Selling General Administrative | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Ebit | N/A | N/A | N/A | N/A | N/A |
| Operating Income | N/A | N/A | N/A | N/A | N/A |
| Income Tax Expense | 117508 | 117508 | -48278 | -48278 | -2583 |
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A |
| Total Other Income Expense Net | N/A | N/A | N/A | N/A | N/A |
| Net Income From Continuing Operations | N/A | N/A | N/A | N/A | N/A |
| Net Income Applicable to Common Shares | 690629 | 690629 | -3.97 million | -3.97 million | -1.17 million |
Cash Flow:
| Date | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 | Jun 30 2019 | Mar 31 2019 |
|---|---|---|---|---|---|
| Investments | N/A | N/A | N/A | N/A | N/A |
| Change to Liabilities | -43625 | -43625 | 194758 | 194758 | -176838 |
| Total Cash Flow from Investing Activities | -4418 | -4418 | -2.74 million | -2.74 million | -268775 |
| Net Borrowings | -1.47 million | -1.47 million | 4.28 million | 4.28 million | 1.25 million |
| Total Cash Flow from Financial Activities | N/A | N/A | N/A | N/A | 4.52 million |
| Change to Operating Activities | 1.33 million | 1.33 million | -649872 | -649872 | 183729 |
| Change in Cash | N/A | N/A | N/A | N/A | 4.49 million |
| Total Cash from Operating Activities | 1.48 million | 1.48 million | -1.01 million | -1.01 million | 237161 |
| Depreciation | N/A | N/A | N/A | N/A | 49118 |
| Other Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Inventory | N/A | N/A | N/A | N/A | 38702 |
| Change to Account Receivables | N/A | N/A | N/A | N/A | -119131 |
| Other Cash Flow from Financing Activities | -479168 | -479168 | -820525 | -820525 | 20845 |
| Change to Net Income | 2.76 million | 2.76 million | N/A | N/A | 29588 |
| Capital Expenditures | N/A | N/A | N/A | N/A | 263135 |
Balance Sheet:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Total Liabailities | N/A | N/A | N/A | N/A | N/A |
| Total Stockholder Equity | N/A | N/A | N/A | N/A | N/A |
| Other Current Liabilities | 3.04 million | 3.04 million | N/A | N/A | N/A |
| Total Assets | N/A | N/A | N/A | N/A | N/A |
| Common Stock | 62057 | 62057 | 34667 | 34667 | 23224 |
| Other Current Assets | 1.97 million | 1.97 million | N/A | N/A | N/A |
| Retained Earnings | -5.82 million | -5.82 million | -7.2 million | -7.2 million | 735803 |
| Other Liabilities | N/A | N/A | N/A | N/A | N/A |
| Other Assets | 23367 | 23367 | 112839 | 112839 | 12679 |
| Cash | N/A | N/A | N/A | N/A | N/A |
| Total Current Liabilities | 5.51 million | 5.51 million | N/A | N/A | N/A |
| Other Stockholder Equity | 48115 | 48115 | -590660 | -590660 | -756920 |
| Property, Plant & Equipment | 1.91 million | 1.91 million | 1.9 million | 1.9 million | 1.94 million |
| Total Current Assets | 22.06 million | 22.06 million | N/A | N/A | N/A |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | 18.47 million | 18.47 million | 9.35 million | 9.35 million | 11.36 million |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A |
| Inventory | 1.35 million | 1.35 million | N/A | N/A | N/A |
| Accounts Payable | 1.36 million | 1.36 million | N/A | N/A | N/A |
China SXT Pharmaceuticals, Inc (SXTC) Chart:
China SXT Pharmaceuticals, Inc (SXTC) News:
Below you will find a list of latest news for China SXT Pharmaceuticals, Inc (SXTC) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
China SXT Pharmaceuticals, Inc (SXTC) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Latest SXTC Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 5:29 PM EST | 100 | $1.72 |
| Jun 13, 2022 5:30 PM EST | 100 | $1.715 |
| Jun 13, 2022 5:30 PM EST | 100 | $1.715 |
| Jun 13, 2022 7:53 PM EST | 200 | $1.715 |
| Jun 13, 2022 7:53 PM EST | 400 | $1.715 |
China SXT Pharmaceuticals, Inc (SXTC) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-05-22 | 6-K/A | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1723980/000121390020013317/0001213900-20-013317-index.htm |
| 2018-01-03 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1723980/000000000018000182/0000000000-18-000182-index.htm |
| 2018-02-05 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1723980/000000000018003936/0000000000-18-003936-index.htm |
| 2018-03-16 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1723980/000000000018008179/0000000000-18-008179-index.htm |
| 2018-04-10 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1723980/000000000018010736/0000000000-18-010736-index.htm |
| 2018-05-01 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1723980/000000000018013382/0000000000-18-013382-index.htm |
| 2018-09-13 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1723980/000000000018028528/0000000000-18-028528-index.htm |
| 2019-06-13 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1723980/000000000019009829/0000000000-19-009829-index.htm |
| 2017-12-04 | F-1 | Registration statement for certain foreign private issuers | https://www.sec.gov/Archives/edgar/data/1723980/000114420417062247/0001144204-17-062247-index.htm |
| 2018-01-19 | F-1/A | Registration statement for certain foreign private issuers | https://www.sec.gov/Archives/edgar/data/1723980/000114420418002891/0001144204-18-002891-index.htm |
| 2018-01-19 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1723980/000114420418002894/0001144204-18-002894-index.htm |
| 2018-03-06 | F-1/A | Registration statement for certain foreign private issuers | https://www.sec.gov/Archives/edgar/data/1723980/000114420418013133/0001144204-18-013133-index.htm |
| 2018-03-06 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1723980/000114420418013137/0001144204-18-013137-index.htm |
| 2018-03-28 | F-1/A | Registration statement for certain foreign private issuers | https://www.sec.gov/Archives/edgar/data/1723980/000114420418017559/0001144204-18-017559-index.htm |
| 2018-03-28 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1723980/000114420418017566/0001144204-18-017566-index.htm |
| 2018-04-20 | F-1/A | Registration statement for certain foreign private issuers | https://www.sec.gov/Archives/edgar/data/1723980/000114420418021554/0001144204-18-021554-index.htm |
| 2018-04-20 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1723980/000114420418021581/0001144204-18-021581-index.htm |
| 2018-05-07 | F-1/A | Registration statement for certain foreign private issuers | https://www.sec.gov/Archives/edgar/data/1723980/000114420418025692/0001144204-18-025692-index.htm |
| 2018-05-07 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1723980/000114420418025698/0001144204-18-025698-index.htm |
| 2018-06-07 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/1723980/000114420418033276/0001144204-18-033276-index.htm |
| 2018-08-17 | F-1/A | Registration statement for certain foreign private issuers | https://www.sec.gov/Archives/edgar/data/1723980/000114420418045380/0001144204-18-045380-index.htm |
| 2018-09-17 | F-1/A | Registration statement for certain foreign private issuers | https://www.sec.gov/Archives/edgar/data/1723980/000114420418049635/0001144204-18-049635-index.htm |
| 2018-09-17 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1723980/000114420418049638/0001144204-18-049638-index.htm |
| 2018-09-26 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1723980/000114420418050940/0001144204-18-050940-index.htm |
| 2018-09-26 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1723980/000114420418050942/0001144204-18-050942-index.htm |
| 2018-09-27 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/1723980/000114420418051157/0001144204-18-051157-index.htm |
| 2018-10-03 | 424B4 | Prospectus [Rule 424(b)(4)] | https://www.sec.gov/Archives/edgar/data/1723980/000114420418052197/0001144204-18-052197-index.htm |
| 2018-11-14 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1723980/000114420418060000/0001144204-18-060000-index.htm |
| 2018-12-26 | 8-A12B | Registration of securities [Section 12(b)] | https://www.sec.gov/Archives/edgar/data/1723980/000114420418066196/0001144204-18-066196-index.htm |
| 2019-02-15 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1723980/000114420419008588/0001144204-19-008588-index.htm |
| 2019-05-08 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1723980/000114420419024432/0001144204-19-024432-index.htm |
| 2019-03-05 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/1723980/000121390019003591/0001213900-19-003591-index.htm |
| 2019-03-28 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1723980/000121390019005023/0001213900-19-005023-index.htm |
| 2019-04-17 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1723980/000121390019006552/0001213900-19-006552-index.htm |
| 2019-05-03 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1723980/000121390019007812/0001213900-19-007812-index.htm |
| 2019-05-30 | F-1 | Registration statement for certain foreign private issuers | https://www.sec.gov/Archives/edgar/data/1723980/000121390019009831/0001213900-19-009831-index.htm |
| 2019-06-21 | F-1/A | Registration statement for certain foreign private issuers | https://www.sec.gov/Archives/edgar/data/1723980/000121390019011250/0001213900-19-011250-index.htm |
| 2019-06-21 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1723980/000121390019011256/0001213900-19-011256-index.htm |
| 2019-06-25 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1723980/000121390019011435/0001213900-19-011435-index.htm |
| 2019-07-31 | NT 20-F | Notification of inability to timely file Form 20-F | https://www.sec.gov/Archives/edgar/data/1723980/000121390019014119/0001213900-19-014119-index.htm |
| 2019-07-31 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1723980/000121390019014165/0001213900-19-014165-index.htm |
| 2019-08-15 | 20-F | Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1723980/000121390019016026/0001213900-19-016026-index.htm |
| 2019-08-19 | 20-F/A | Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1723980/000121390019016250/0001213900-19-016250-index.htm |
| 2019-11-05 | 424B8 | Prospectus filed pursuant to Rule 424(b)(8) | https://www.sec.gov/Archives/edgar/data/1723980/000121390019022024/0001213900-19-022024-index.htm |
| 2019-12-16 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1723980/000121390019026190/0001213900-19-026190-index.htm |
| 2020-01-31 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1723980/000121390020002223/0001213900-20-002223-index.htm |
| 2020-03-04 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1723980/000121390020005362/0001213900-20-005362-index.htm |
| 2020-03-10 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1723980/000121390020005884/0001213900-20-005884-index.htm |
| 2020-03-31 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1723980/000121390020008197/0001213900-20-008197-index.htm |
| 2020-04-22 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1723980/000121390020009835/0001213900-20-009835-index.htm |
| 2020-05-22 | 6-K/A | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1723980/000121390020013317/0001213900-20-013317-index.htm |
| 2020-07-10 | 6-K | Report of foreign issuer [Rules 13a-16 and 15d-16] | https://www.sec.gov/Archives/edgar/data/1723980/000121390020017121/0001213900-20-017121-index.htm |
| 2020-07-31 | 20-F | Annual and transition report of foreign private issuers [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1723980/000121390020019503/0001213900-20-019503-index.htm |
| 2019-01-02 | CERT | Certification | https://www.sec.gov/Archives/edgar/data/1723980/000135445719000002/0001354457-19-000002-index.htm |
| 2020-02-07 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1723980/000139382520000087/0001393825-20-000087-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1723980/000149315220002422/0001493152-20-002422-index.htm |
| 2018-09-28 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1723980/999999999518002492/9999999995-18-002492-index.htm |
| 2019-06-27 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1723980/999999999519001461/9999999995-19-001461-index.htm |